Publications


Heinzman JT, Hoth KF, Cho MH, Sakornsakolpat P, Regan EA, Make BJ, Kinney GL, Wamboldt FS, Holm KE, Bormann N, Robles J, Kim V, Iyer AS, Silverman EK, Crapo JD, Han S, Potash JB, Shinozaki G, COPDGene Investigators: GWAS and Systems Biology Analysis of Depressive Symptoms among Smokers from the COPDGene Cohort.  J Affect Disord. 2018 Sep 7; 243:16-22.

[PubMed

 

Chan AC, Burke CA, Coffey EM, Hilden DR, Coira DL, Warner-Cohen J, Grady M, Muskin PR, Shinozaki GIntegrated Inpatient Medical and Psychiatric Care: Experiences of 5 Institutions. Ann Intern Med. 2018 Jun 5;168(11):815-817. doi: 10.7326/M17-3186. Epub 2018 Apr 24. PMID: 29710091

 

Sumner JA, Duncan LE, Wolf EJ, Amstadter AB, Baker DG, Beckham JC, Gelaye B, Hemmings S, Kimbrel NA, Logue MW, Michopoulos V, Mitchell KS, Nievergelt C, Rothbaum A, Seedat S, Shinozaki G, Vermetten E. Letter to the Editor: Posttraumatic stress disorder has genetic overlap with cardiometabolic traits. Psychol Med. 2017 Apr 4:1-4. [Pub Med]

 

Mrazek D, Biernacka J, McAlpine D, Benitez J, Karpyak V, Williams M, Hall-Flavin D, Netzel P, Passov V, Rohland B, Shinozaki G, Hoberg A, Snyder K, Drews M, Skime M, Sagen J, Schaid D, Weinshilboum R, Katzelnick D. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study. J Clin Psychopharmacol. 2014 June. 34(3):313-7.

 

Shinozaki G, Kung S, Mrazek D. Does 5HTTLPR long allele prevent hospitalization? Test of Hardy-Weinberg equilibrium. Psychiatr Genet. 2014 February. 24(1):34-6. [PubMed

Shinozaki G, Hing B, Potash J. Chapter 13: Epigenetics of bipolar disorder. Academic Press. 2014. 

Kumar Y, Kung S, Shinozaki G. CYP2C19 variation, citalopram dose and QTc prolongation on electrocardiogram. J Psychopharmacol. 2014. 28(12):1143-1148. [PubMed

Shinozaki G, Potash J. New developments in the genetics of bipolar disorder. Curr Psychiatry Rep. 2014. 16(11):493. [PubMed

Shinozaki G, Kumar Y, Rosen B, Rundell J, Mrazek D, Kung S. Diminished association between the serotonin transporter linked polymorphism (5HTTLPR) and body mass index in a large psychiatric sample. J Affect Disord. 2013 October. 151(1):397-400. [PubMed

Shinozaki G, Romanowicz M, Mrazek D, Kung S. HTR2A gene-child abuse interaction and association with a history of suicide attempt among Caucasian depressed psychiatric inpatients. J Affect Disord. 2013 September 25. 150(3):1200-3. [PubMed

Shinozaki G, Romanowicz M, Passov V, Rundell J, Mrazek D, Kung S. State dependent gene-environment interaction: serotonin transporter gene-child abuse interaction associated with suicide attempt history among depressed psychiatric inpatients. J Affect Disord. 2013 May. 147(1-3):373-8. [PubMed

Romanowicz M, Ehlers S, Walker D, Decker P, Rundell J, Shinozaki G, Litzow M, Hogan W, Mrazek D, Black J. Testing a diathesis-stress model: potential genetic risk factors for development of distress in context of acute leukemia diagnosis and transplant. Psychosomatics. 2012 September. 53(5):456-62. [PubMed

Shinozaki G, Romanowicz M, Kung S, Rundell J, Mrazek D. Investigation of serotonin transporter gene (SLC6A4) by child abuse history interaction with body mass index and diabetes mellitus of White female depressed psychiatric inpatients. Psychiatr Genet. 2012 June. 22(3):109-14. [PubMed

Shinozaki G. The integrated model of serotonin transporter gene variation (5HTTLPR) and the glial cell transporter in stress vulnerability and depression. Med Hypotheses. 2012 March. 78(3):410-4. [PubMed

Shinozaki G, Jowsey S, Amer H, Biernacka J, Colby C, Walker D, Black J, Rundell J, Stegall M, Mrazek D. Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients. Depress Anxiety. 2011 December 21. 28(12):1111-8. [PubMed]

Das P, Shinozaki G, McAlpine D. Post-pump chorea--choreiform movements developing after pulmonary thromboendarterectomy for chronic pulmonary hypertension presenting as functional movement disorder. Psychosomatics. 2011 September. 52(5):459-62. [PubMed

Shinozaki G. Continuous un-SERT-ainty of 5-HTTLPR. Pharmacogenomics. 2011 July. 12(7):935-8. [PubMed

Shinozaki G, Romanowicz M, Kung S, Mrazek D. A new interaction between SLC6A4 variation and child abuse is associated with resting heart rate. Depress Anxiety. 2011 March. 28(3):227-33. 
[PubMed

Rundell J, Staab J, Shinozaki G, Saad-Pendergrass D, Moore K, McAlpine D, Mrazek D. Pharmacogenomic testing in a tertiary care outpatient psychosomatic medicine practice. Psychosomatics. 2011 March. 52(2):141-6. [PubMed

Rundell J, Staab J, Shinozaki G, McAlpine D. Serotonin transporter gene promotor polymorphism (5-HTTLPR) associations with number of psychotropic medication trials in a tertiary care outpatient psychiatric consultation practice. Psychosomatics. 2011 March. 52(2):147-53. [PubMed

Sprangers M, Bartels M, Veenhoven R, Baas F, Martin N, Mosing M, Movsas B, Ropka M, Shinozaki G, Swaab D, GENEQOL Consortium. Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Qual Life Res. 2010 December. 19(10):1429-37. 

Chen L, Murad M, Paras M, Colbenson K, Sattler A, Goranson E, Elamin M, Seime R, Shinozaki G, Prokop L, Zirakzadeh A. Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis. Mayo Clin Proc. 2010 July. 85(7):618-29. 

Rundell J, Shinozaki G. Pharmacogenomic considerations in patients with comorbid medical and psychiatric illness. Primary Psychiatry. 2010 May. 17(5):33-8. 

Sprangers M, Sloan J, Veenhoven R, Cleeland C, Halyard M, Abertnethy A, Baas F, Barsevick A, Bartels N, Boomsma D, Chauhan C, Dueck A, Frost M, Hall P, Klepstad P, Martin N, Miaskowski C, Mosing M, Movsas B, Van Noorden C, Patrick D, Pedersen N, Ropka M, Shi Q, Shinozaki G, Singh J, Yang P, Zwinderman A. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res Hum Genet. 2009 June. 12(3):301-11.